NeOnc Technologies Holdings is trading 5.29% down now at $3.13 amid broader biotechnology-sector pressure, with XBI down 2.11%.
- Opening weakness continued from the September 15 close of $3.31.
- No clear company-specific negative announcement was identified for September 16; recent insider purchases provide conflicting sentiment, not a confirmed catalyst.
- The September 9 financing remains a potential dilution overhang but does not directly explain today's move.